Pence-davis Medical Center | |
2651 S 800 W Swayzee IN 46986-9615 | |
(765) 922-7056 | |
(765) 922-7059 |
Full Name | Pence-davis Medical Center |
---|---|
Speciality | Family Medicine |
Location | 2651 S 800 W, Swayzee, Indiana |
Authorized Official Name and Position | Paul Usher L (PRESIDENT/CEO) |
Authorized Official Contact | 7656624776 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Pence-davis Medical Center 1251 W Kem Rd Suite E Marion IN 46952-2555 Ph: (765) 662-4133 | Pence-davis Medical Center 2651 S 800 W Swayzee IN 46986-9615 Ph: (765) 922-7056 |
NPI Number | 1588717813 |
---|---|
Provider Enumeration Date | 01/19/2007 |
Last Update Date | 02/19/2009 |
Identifier | Type | State | Issuer |
---|---|---|---|
1588717813 | NPI | - | NPPES |
100269250 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
New York University College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
In a new study a genetic mutation was found in the most common form of ovarian cancer. This according to the US scientists could pave the way for a more effective treatment of the disease. The detailed genetic map already helped scientists identify existing drugs with the potential for treating the mutations found in ovarian cancer tumors and also identified mutations that could respond to new drugs.
A new scientific study reveals one way to stop proteins from triggering an energy failure inside nerve cells during Huntington's disease. Huntington's disease is an inherited genetic disorder caused by mutations in the gene that encodes huntingtin protein.
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
› Verified 7 days ago